Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Inventory (2016 - 2025)

Haemonetics (HAE) has 16 years of Inventory data on record, last reported at $321.2 million in Q4 2025.

  • For Q4 2025, Inventory rose 1316.61% year-over-year to $321.2 million; the TTM value through Dec 2025 reached $321.2 million, up 1316.61%, while the annual FY2025 figure was $365.1 million, 15.11% up from the prior year.
  • Inventory reached $321.2 million in Q4 2025 per HAE's latest filing, down from $336.2 million in the prior quarter.
  • Across five years, Inventory topped out at $382.1 million in Q3 2024 and bottomed at -$26.4 million in Q4 2024.
  • Average Inventory over 5 years is $296.4 million, with a median of $311.5 million recorded in 2022.
  • Peak YoY movement for Inventory: crashed 108.68% in 2024, then surged 1316.61% in 2025.
  • A 5-year view of Inventory shows it stood at $322.7 million in 2021, then decreased by 20.74% to $255.8 million in 2022, then grew by 18.87% to $304.0 million in 2023, then plummeted by 108.68% to -$26.4 million in 2024, then soared by 1316.61% to $321.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $321.2 million in Q4 2025, $336.2 million in Q3 2025, and $360.5 million in Q2 2025.